Drugs Market Research Reports & Industry Analysis

... . SCOPE OF HUMAN PARAINFLUENZA VIRUS 3 (HPIV-3) INFECTION PIPELINE REPORT INCLUDES Panorama of Human Parainfluenza Virus 3 (HPIV-3) Infection pipeline markets including statistics on therapeutic drugs and companies involved Human Parainfluenza Virus 3 (HPIV-3) Infection Pipeline ...

Japanese Encephalitis (JEV) Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Japanese Encephalitis (JEV) Infection pipeline products. DISEASE OVERVIEW Japanese encephalitis virus or JAVEX is a viral ...

Klebsiella pneumoniae Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Klebsiella pneumoniae pipeline products. DISEASE OVERVIEW Klebsiella pneumoniae belongs to the class of Gram-negative bacteria ...

Leishmaniasis (Kala-azar) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Leishmaniasis (Kala-azar) pipeline products. DISEASE OVERVIEW Leishmaniasis is one of the most researched areas among ...

Meningococcus (Neisseria meningitidis Infection) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Meningococcus (Neisseria meningitidis Infection) pipeline products. DISEASE OVERVIEW Meningococcal infection is one of the ...

Progressive Multifocal Leukoencephalopathy (PML) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Progressive Multifocal Leukoencephalopathy (PML) pipeline products. DISEASE OVERVIEW Progressive multifocal leukoencephalopathy (PML) is a ...

... . SCOPE OF Q-FEVER (QUERY FEVER) PIPELINE REPORT INCLUDES Panorama of Q-Fever (Query Fever) pipeline markets including statistics on therapeutic drugs and companies involved Q-Fever (Query Fever) Pipeline candidates across various development phases ...

Rabies Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Rabies pipeline products. DISEASE OVERVIEW Human rabies is rare but fatal disease causing 50,000 ...

Rotavirus Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Rotavirus pipeline products. DISEASE OVERVIEW Rotavirus virus symptoms include diarrhea, nausea and stomach ...

Rubella (German measles) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Rubella (German measles) pipeline products. DISEASE OVERVIEW Rubella virus is one of the key ...

Tetanus Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Tetanus Infection pipeline products. DISEASE OVERVIEW Tetanus infection is spread through Clostridium tetani bacteria, which ...

Tularaemia (Rabbit Fever) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Tularaemia (Rabbit Fever) pipeline products. DISEASE OVERVIEW Tularaemia or Francisella tularensis infection or Rabbit Fever is a catastrophic ...

... use format. SCOPE OF VANCOMYCIN RESISTANT ENTEROCOCCAL (VRE) INFECTION PIPELINE REPORT INCLUDES Panorama of Vancomycin Resistant Enterococcal (VRE) Infection pipeline markets including statistics on therapeutic drugs and companies involved Vancomycin Resistant Enterococcal (VRE) Infection Pipeline candidates ...

Yellow Fever Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Yellow Fever pipeline products. DISEASE OVERVIEW Yellow fever is a mosquito-borne infection that ranges from ...

... /Hypertension drugs monitoring Device Market Research and Analysis, By Drugs 3. Global High blood pressure/Hypertension drugs monitoring Device Market Research and Analysis, By Monitoring Devices 4. Global High blood pressure/Hypertension drugs ...

... of Insulin Glargine Supply of and demand for Insulin Glargine in China Major Insulin Glargine manufacturers in China Prices of Insulin Glargine in China Factors influencing the development of the Chinese Insulin Glargine market from 2018 to 2022 Prospect of the Chinese Insulin Glargine ...

... years. TOPICS COVERED: Development environment of Ossotide Sales of Ossotide in China Competition pattern of Chinese Ossotide Market Major Ossotide manufacturers in China Prices of Ossotide in China Prospect of the Chinese Ossotide market from 2018 to 2022

According to Stratistics MRC, the Global Probiotics market is accounted for $42.64 billion in 2017 and is expected to reach $87.91 billion by 2026 ... across the western countries and technological advancements in probiotic products are propelling the market growth. In addition, government support and rising ...

Global Pharmacovigilance and Drug Safety Software Market to reach USD 265.2 billion by 2025. Global Pharmacovigilance and Drug Safety Software Market valued approximately USD 150 ... the major players. Target Audience of the Global Pharmacovigilance and Drug Safety Software Market In Market Study: Key Consulting ...

... regulatory approval process are hampering the growth of the market. Market Analysis: The “global drug-eluting stents market” is estimated to witness a CAGR of 5.4% during the forecast period 2018 ...

... improving healthcare facilities. The global orphan drugs market is expected to grow in future due to prolonged orphan drug market exclusivity, increasing sales of prescription drugs, attractive orphan drug policies, rising healthcare expenditure ...

... government policies impacting the Global Cardiovascular drug market. Insights about market determinants which are stimulating the Global Cardiovascular drug market. Detailed and extensive market segments with regional distribution ...

... growth potential for the Chinese Rituximab market. Topics Covered: Development environment of Chinese Rituximab market Sales of Rituximab in China Prices of Rituximab in China Progress of generic Rituximab in China Prospects of Chinese Rituximab Market, 2018-2022

... and the increase of residents' income. Topics Covered: Development environment of Epoetin Alfa in China Demand for Epoetin Alfa in China Major Epoetin Alfa Manufacturers in China Prices of Epoetin Alfa in China Prospects of Chinese Epoetin Alfa Market

... : Global Respiratory drug market Research and Analysis, By Drug Global Respiratory drug market Research and Analysis, By Drug Class Global Respiratory drug market Research and Analysis, By Route of Administration Global Respiratory drug market Research and Analysis, By End User Global Respiratory drug market ...

... environment of Imatinib in China Forecast on market size of Imatinib in China Market share of major Imatinib manufacturers in China Retail prices of Imatinib in China Development of generic Imatinib in China India-made Imatinib smuggled to China Prospects of Chinese Imatinib market, 2018 ...

... -operative medications, and thus a high demand for Latanoprost in China. Topics Covered: Development environment of Latanoprost in China Sales of Latanoprost in China Major Latanoprost manufacturers in China Retail prices of Latanoprost in China Prospects of Chinese Latanoprost market

... that China-made Sorafenib will appear on the market after 2022. Topics Covered: Sales of Sorafenib in China Prices of Sorafenib in China Sales of Sorafenib in China by region Sales of India-made Sorafenib in China Prospects of Chinese Sorafenib ...

... China, with its sales value increasing from less than CNY 7 million in 2015 to more than CNY 1.2 billion in 2017. The Chinese Thymosin ... Size of Chinese Thymosin α1 market Competition pattern of the Chinese Thymosin α1 market Prices in the Chinese Thymosin α1 market Prospects of the Chinese Thymosin α1 market

... government policies impacting the global 3D Printed Drugs Market Insights about market determinants which are stimulating the global 3D Printed Drugs Market Detailed and extensive market segments with regional distribution ...

... are many manufacturers and fierce competitions in the market. Thymopentin is only sold in China as a Chinese-style drug. According to CRI, in 2017, the ... sales value of Thymopentin exceeded CNY 1 billion in the Chinese market dominated by ...

... Chinese Deproteinized Calf Blood Extractives market Size of the Chinese Deproteinized Calf Blood Extractives market Competition pattern of the Chinese Deproteinized Calf Blood Extractives market Prices in the Chinese Deproteinized Calf Blood Extractives market Forecast on the Chinese Deproteinized Calf Blood ...

... exceeded 90% in 2017. Topics Covered: Development history of Ioversol in China Size of China Ioversol market Competition Pattern of Chinese Ioversol market Prices in the Chinese Ioversol market Prospects of Chinese Ioversol Market, 2018-2022

... of Valsartan in China Sales of Valsartan in China, 2013-2017 Market share of major Valsartan manufacturers in China Sales of Valsartan in different dosage forms in China Average price of Valsartan in China Average prices of major manufacturers' Valsartan in China Prospects of Chinese Valsartan ...

... for the Chinese Enoxaparin Sodium market. Topics Covered: Incidence of thrombosis in China Development history of Enoxaparin Sodium in China Sales of Enoxaparin Sodium in China Prices of Enoxaparin Sodium in China Major Enoxaparin Sodium manufacturers in China Prospects of Chinese Enoxaparin Sodium Market

... History of Clopidogrel in Chinese Market Development Environment of Clopidogrel in China Sales of Clopidogrel in China Major Clopidogrel Manufacturers in Chinese Market Sale Price of Clopidogrel in Chinese Market Prospects of Chinese Clopidogrel Market, 2018 ...

... period. The report segments the migraine drugs market based on type, route of administration, distribution channel, and region. Based on type, the market is bifurcated into abortive medicine ...

... represents the global and regional analysis of Paracetamol in terms of Dosage, Strength, API, application (Pharmaceutical, Chemical, Agrochemical & Dye) Wise segmentation, market size & market growth (in terms ...

... as new technologies are expected to increase the demand for cognition and memory-enhancing drugs in the market. However, the major restricting aspect of the global cognition and memory-enhancing drugs market is the ...

Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request. The healthcare industry is a multi-billion d...

... COVERED Development history of Budesonide in China Size of Chinese Budesonide market Market share of major Budesonide manufacturers in China Market share of various dosage forms of Budesonide in China Budesonide prices on the Chinese ...

... synthesis, analysis, and interpretation of information about the global vitamin & mineral premixes market collected from specialized sources. The competitive landscape section ... key drivers that are impacting the demand in global vitamin & mineral premixes market. Key Regions North America Europe Asia Pacific ...

... , analysis, and interpretation of information about the global vitamin premixes market collected from specialized sources. The competitive landscape section ... global vitamin premixes market? What are the challenges to market growth? Who are the key players in the vitamin premixes market? What are the market ...

... million people are hospitalized due to ACS annually. The acute coronary syndrome is a common complication of coronary heart disease. ACS refers to a broad range of ... developments, orphan drug/ fast track/ other designations, drug class are provided for each Acute Coronary Syndrome pipeline product. Mechanism ...

2018 Acute Heart Failure Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Acute Heart Failure Market is a comprehensive report on Acute Heart Failure pipeline. To assist researchers, investors and business development ...

... managers, VPA Research has come up with a comprehensive report on Angina Pectoris Or Ischemic Chest Pain pipeline. The report provides insights into different ... details of each product, the report provides key trends in Angina Pectoris Or Ischemic Chest Pain pipeline studies. The products under development are ...

... companies and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Arrhythmia pipeline product. Mechanism of Action and ...

... and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Arterial Thrombosis pipeline product. ... provides key trends in Arterial Thrombosis pipeline studies. The products under development are categorized according to their development phase, mechanism and ...

... and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Atherosclerotic Heart Disease pipeline product. Mechanism of Action ...

... and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Behcet'S Disease pipeline product. ... provides key trends in Behcet'S Disease pipeline studies. The products under development are categorized according to their development phase, mechanism and ...